(PharmaNewsWire.Com, January 10, 2020 ) According to research report the vascular imaging market is expected to reach USD 5.95 billion by 2022 from USD 4.35 billion in 2017, at a CAGR of 6.5%. The report covers imaging procedures used to assess blood flow for the effective diagnosis and treatment of various cardiovascular diseases (CVDs).
The vascular imaging market is consolidated in nature due to the presence of large players. The key players in this market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea), Pie Medical Imaging (Netherlands), CorVascular Diagnostics LLC (U.S.), Evena Medical, Inc. (U.S.), LumedX Healthcare Technologies (U.S.), Xograph Healthcare (U.K.), Mindray Medical International Ltd. (China), Novadaq Technologies Inc. (Canada), Omega Medical Imaging LLC. (U.S.), BK Ultrasound (U.S.), and Piur imaging GmbH (Austria).
• Based on technique, the market is segmented into MRI, CT, ultrasound, nuclear imaging, and X-ray. The MRI segment is expected to dominate the global vascular imaging market throughout the forecast period. The increasing incidence of CVDs and the launch of advanced MRI systems are the key factors driving the growth of this segment. • Based on applications, the market has been segmented into diagnostic and therapeutic applications. The therapeutic applications segment is expected to register the highest growth during the forecast period primarily due to the growing use of imaging techniques in surgeries & treatments. • Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and other end users. Currently, hospitals are the largest end users of vascular imaging systems. This end-user segment is also expected to register the highest growth during the forecast period. The increasing prevalence of CVDs (resulting in the increased demand for non-invasive techniques), technological advancements, and rising demand for advanced systems in operating rooms (especially in developed countries across North America and Europe) are the major factors driving the growth of this end-user segment.
Major industry players launched innovative products in the recent past and have plans to launch new products and expand across geographies by partnerships and acquisitions. GE Healthcare, Siemens Healthineers, and Toshiba Medical Systems Corporation are identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. Further, these leaders have products for all end users in this segment, have a strong geographical presence, and more importantly focus on continuous product innovations.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 firstname.lastname@example.org
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: